FDA Inspection 1080994 — Coloplast Manufacturing US, LLC

Coloplast Manufacturing US, LLC — FEI 2125050

The FDA completed an inspection of Coloplast Manufacturing US, LLC on Feb 6, 2019 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 6, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minneapolis, MN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.